Following in New York's footsteps, California's state health department has sent cease-and-desist orders to 13 consumer genomics companies, reports Forbes.com. In California, the law is that laboratory tests -- including genetic tests -- have to be ordered by a physician and must be validated for accuracy and medical utility. A spokeswoman said that California's investigation was prompted by consumer complaints. "The consumers were unhappy about the accuracy [of the tests] and thought they cost too much," she said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.